SOLTF Projected Dividend Yield
Ord/Nxera Pharma Co Ltd ( OTCBB : SOLTF )Sosei Group is a biopharmaceutical holding company. Co. through its subsidiaries, is engaged in the discover and development of drugs for the treatment of Alzheimer's disease, schizophrenia, cancer, migraine, addiction, metabolic disease, and other indications. Co. establishes product pipeline by utilizing its platform technologies, GPCR structure-based drug design platform technology and peptide platform technologies. Co.'s development and commercialization partners, including Pfizer, NEUROCRINE BIOSCIENCES, GSK, Genentech, Takeda, abbvie, Lilly, sanofi, PepptiDream, metrion biosciences, PHARMENABLE, InveniAI, verily, KALLYOPE, TEMPERO BIO, and Orexia Therapeutics. 20 YEAR PERFORMANCE RESULTS |
SOLTF Dividend History Detail SOLTF Dividend News SOLTF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |